- Home
- AUUD vs BBLG Comparison
AUUD vs BBLG Comparison
Compare AUUD & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUUD | BBLG |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 2.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AUUD | BBLG |
|---|---|---|
| Price | $1.06 | $1.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 169.4K | 60.6K |
| Earning Date | 03-04-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.82 | $1.30 |
| 52 Week High | $14.60 | $7.74 |
Technical Indicators
Market Signals| Indicator | AUUD | BBLG |
|---|---|---|
| Relative Strength Index (RSI) | 51.61 | 54.14 |
| Support Level | $0.95 | $1.58 |
| Resistance Level | $1.22 | $1.88 |
| Average True Range (ATR) | 0.10 | 0.10 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 59.30 | 75.03 |
Price Performance
Historical ComparisonAbout AUUD Auddia Inc.
Auddia Inc is a technology company that is engaged in radio broadcasts and streaming audio content digitally. Its products includes Auddia App which is a subscription-based commercial-free AM/FM software application, and Vodacast an interactive podcasting platform and application. The company generates revenue through subscription fees from customers accessing the company's cloud-based computing services and advertisement services.
About BBLG Bone Biologics Corp
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.